Governance Committee
Composed of the initiative’s management team, stakeholders and future users of the infrastructure developed, the governance committee has for role i) decision-making on the various aspects related to the progress of the initiative, ii) transferring or disseminating results, iii) monitoring the success indicators and socio-economic benefits of the initiative, and iv) promoting the initiative in the Quebec science ecosystem of life.
Jean-Claude Tardif, MD
Director of the Montreal Heart Institute Research Center and Chair of the Committee.
Daniel Gaudet, MD, PhD
Scientific Director of Ecogène-21.
Frédéric Lesage, PhD, MBA, Ing.
Associate Director of the Montreal Heart Institute Research Center.
Sophie Tanguay, MSc
Executive Director, Montreal Health Innovations Coordinating Center (MHICC)
Sylvain Bédard
Patient Partner, Centre of Excellence on Partnership with Patients and the Public.
Ma’n Zawati, LL.B, LL.M, PhD
Executive Director of the Centre of Genomics and Policy at McGill University
Nicolas Beaudet, PhD
Director, Scientific Affairs at Omnimed.
Pierre Laurin, MSc, MBA
Chief Executive Officer of Ingenew Pharma and InvHealth Capital.
Marie-Thérèse Lussier, MD, BSc, MSc, FCMF
Director, Réseau de recherche en soins primaires of the Université de Montréal (RRSPUM)
Vincent Poitout, DVM, PhD, FCAHS
Director of research, Centre Hospitalier de l’Université de Montréal (CHUM).
Zamzam Akbaraly
Patient partner, Centre of Excellence on Partnership with Patients and the Public (CEPPP).